Edgewise Therapeutics, Inc. (EWTX) Misses Q2 EPS by 6c

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q2 EPS of ($0.53), $0.06 worse than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.

You May Also Be Interested In

• Four key things investors will watch in Nvidia's earnings next week
• Alpha Tau Medical Ltd. (DRTS) PT Raised to $16 at H.C. Wainwright
• Hemab Therapeutics Holdings (COAG) PT Raised to $60 at H.C. Wainwright